The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomised Trial of Paclitaxel (PTX) and Carboplatin (CBDCA) Versus a Control Arm of Carboplatin or CAP (Cyclophosphamide, Doxorubicin & Cisplatin): The Third International Collaborative Ovarian Neoplasm Study (ICON3).
 
Masaki Shiota
Honoraria - Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Janssen; Sanofi
 
Naohiro Fujimoto
No Relationships to Disclose
 
Kenjiro Imada
No Relationships to Disclose
 
Eiji Kashiwagi
No Relationships to Disclose
 
Ario Takeuchi
No Relationships to Disclose
 
Junichi Inokuchi
No Relationships to Disclose
 
Katsunori Tatsugami
Speakers' Bureau - Bayer Yakuhin; Pfizer
 
Shunichi Kajioka
Research Funding - Astellas Pharma
 
Takeshi Uchiumi
No Relationships to Disclose
 
Masatoshi Eto
Honoraria - Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Bristol-Myers Squibb Japan; Janssen; Ono Pharmaceutical; Pfizer; Sanofi